Clinical Trial Information

Trials

Studies that name Clinical Trial Information as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:22 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT07682818 · Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function

  Zealand Pharma · recruiting · Impaired Hepatic Function · principal investigator
• Ph1
  NCT07073183 · Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC)

  CureVac · withdrawn · Squamous NSCLC · study director
• Ph1
  NCT05938387 · Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma

  CureVac · completed · Glioblastoma · study director
• N/A
  NCT04295278 · Feasibility Study of MicroKine Dx System in Critically-ill Pediatric Patients.

  PreDxion Bio, Inc. · unknown · Multiple Organ Failure · study director
• N/A
  NCT04271280 · Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events

  Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · completed · Dyslipidemia, Cardiovascular Diseases, Hypercholesterolemia · study director
• Ph3
  NCT03941236 · Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism

  Zealand Pharma · completed · Congenital Hyperinsulinism · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.